Fluconazole Disk Diffusion Susceptibility Testing ofCandida Species

ABSTRACT We describe a simple procedure for detecting fluconazole-resistant yeasts by a disk diffusion method. Forty clinical Candidasp. isolates were tested on RPMI-glucose agar with either 25- or 50-μg fluconazole disks. With 25-μg disks, zones of inhibition of ≥20 mm at 24 h accurately identified 29 of 29 isolates for which MICs were ≤8 μg/ml, and with 50-μg disks, zones of ≥27 mm identified 28 of 29 such isolates. All 11 isolates for which MICs were >8 μg/ml were identified by using either disk. Disk diffusion may be a useful screening method for clinical microbiology laboratories.

[1]  M. Ghannoum,et al.  Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Labora , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  M. Rinaldi,et al.  Comparative evaluation of macrodilution and chromogenic agar screening for determining fluconazole susceptibility of Candida albicans , 1996, Journal of clinical microbiology.

[3]  S. Redding,et al.  Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patients. , 1996, The Journal of infectious diseases.

[4]  A. Barry,et al.  Fluconazole disk diffusion procedure for determining susceptibility of Candida species , 1996, Journal of clinical microbiology.

[5]  S. Redding,et al.  Simple method for detecting fluconazole-resistant yeasts with chromogenic agar , 1996, Journal of clinical microbiology.

[6]  M. Ghannoum,et al.  Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome , 1996, Journal of clinical microbiology.

[7]  G. Gilbert,et al.  Antifungal susceptibility testing using the E test: comparison with the broth macrodilution technique. , 1996, The Journal of antimicrobial chemotherapy.

[8]  M. Ghannoum,et al.  In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans , 1995, Antimicrobial agents and chemotherapy.

[9]  M. Rinaldi,et al.  Comparative evaluation of macrodilution and alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates , 1995, Journal of clinical microbiology.

[10]  M. Rinaldi,et al.  Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing , 1995, Journal of clinical microbiology.

[11]  J. Rex,et al.  Resistance of Candida species to fluconazole , 1995, Antimicrobial agents and chemotherapy.

[12]  J. Rex,et al.  Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group , 1995, Antimicrobial agents and chemotherapy.

[13]  M. Rinaldi,et al.  Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard , 1994, Journal of clinical microbiology.

[14]  M. Pfaller,et al.  Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates , 1994, Journal of clinical microbiology.

[15]  G. Reboux,et al.  Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype , 1994, Journal of clinical microbiology.

[16]  J. Galgiani,et al.  Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts , 1993, Antimicrobial Agents and Chemotherapy.

[17]  J. Galgiani,et al.  Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests , 1992, Journal of clinical microbiology.

[18]  R. Eng,et al.  Development of resistance in candida isolates from patients receiving prolonged antifungal therapy , 1991, Antimicrobial Agents and Chemotherapy.

[19]  M. Pfaller,et al.  Multicenter evaluation of four methods of yeast inoculum preparation , 1988, Journal of clinical microbiology.

[20]  E. Bruck,et al.  National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.

[21]  J. Rex,et al.  Antifungal Susceptibility Testing of Isolates from a Randomized, Multicenter Trial of Fluconazole versus Amphotericin B as Treatment of Nonneutropenic Patients with Candidemia , 1994 .

[22]  H. Dermoumi.  In vitro susceptibility of yeast isolates from the blood to fluconazole and amphotericin B. , 1992, Chemotherapy.